Moneycontrol PRO
HomeNewsSunpharmaceuticalindustries

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Brokerages upgraded these 35 stocks in November; expect returns up to 40%

    The most noted point after September quarter earnings season was that more than 100 stocks witnessed upgrade in rating to buy from brokerages.

  • HCL Tech, Sun Pharma among 10 largecap names that can give 8-30% returns in a year

    HCL Tech, Sun Pharma among 10 largecap names that can give 8-30% returns in a year

    Analysts and brokerage firms are bullish on market prospects as events such as the US election is over and positive reports on the vaccine front are giving hopes that soon COVID-19 will be under control.

  • Hot Stocks | Trading opportunity in OFSS, HDFC Life and Sun Pharma for short term

    Hot Stocks | Trading opportunity in OFSS, HDFC Life and Sun Pharma for short term

    Nifty, on a daily timeframe, is trading within a flag formation which is bounded in the range between 11,650 to 12,025 levels.

  • 'Choppy trade may continue with 11,250 acting as crucial level; 3 buy ideas for short term'

    'Choppy trade may continue with 11,250 acting as crucial level; 3 buy ideas for short term'

    In case 11,250 is breached, the downside remains open towards 11,000-10,900 zone.

  • Experts bet on these 18 stocks after Q1 earnings; do you own any?

    Experts bet on these 18 stocks after Q1 earnings; do you own any?

    IT and pharma are preferred themes by experts after June quarter earnings

  • Hot Stocks | Here's why Sun Pharma, Tata Power and Hindalco are a buy for short term

    Hot Stocks | Here's why Sun Pharma, Tata Power and Hindalco are a buy for short term

    The benchmark index is just a few points away from the recent top of 11,341 which also happens to be the highest point of the rally started since March 2020.

  • Hot Stocks | Jubilant Foodworks, Sun Pharma two buy calls for the short term

    Hot Stocks | Jubilant Foodworks, Sun Pharma two buy calls for the short term

    Liquidity driven rally has almost completed 78.60 percent retracement of the entire downswing seen from January 2020 top to March 2020 bottom.

  • 'Bulls ready to take Nifty towards 11k despite short-term correction; 3 bets for double-digit returns'

    'Bulls ready to take Nifty towards 11k despite short-term correction; 3 bets for double-digit returns'

    In the very short term, as the majority of the momentum indicators are trading in overbought zones, the possibility of small retracement towards 10,500 levels cannot be denied.

  • Pharma: Is the show over or are there some fireworks left?

    Pharma: Is the show over or are there some fireworks left?

    After some tough years, the pharma sector is performing well and is around 25 percent up while the broader market is down 20 percent year-to-date.

  • Hot Stocks | Sun Pharma, PFC, ICICI Pru Life can give up to 22% return in short term

    Hot Stocks | Sun Pharma, PFC, ICICI Pru Life can give up to 22% return in short term

    The geopolitical concerns could continue to keep markets jittery but the technical set up and bounce look good for a higher move to cross the recent high of 10,325 levels.

  • Hot Stocks | Sun Pharma, Lupin, Torrent Pharma are three short-term ideas

    Hot Stocks | Sun Pharma, Lupin, Torrent Pharma are three short-term ideas

    After bearish development on the short-term charts, Nifty has not seen follow up selling. The level of 9,100 has been acting as strong support for the index.

  • Hot Stocks | Sun Pharma, HDFC Life are buys for short term

    Hot Stocks | Sun Pharma, HDFC Life are buys for short term

    Once we see Nifty surpassing the higher boundary of 9,450, we would see a good broad-based participation in the market.

  • Pharma index up 45% from March lows; CLSA says earnings momentum to continue, raises targets

    Pharma index up 45% from March lows; CLSA says earnings momentum to continue, raises targets

    The Nifty Pharma index gained half a percent on May 7, taking gains to around 45 percent since March 23.

  • Experts say these 7 stocks are a good long-term bet amid virus-led crisis

    Experts say these 7 stocks are a good long-term bet amid virus-led crisis

    There's no relief from the COVID-19 front as the numbers are not showing any signs of slowing down yet and that could result in further extension of the lockdown, said Ajit Mishra of Religare Broking.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Mitessh Thakkar of mitesshthakkar.com recommends buying Apollo Hospitals with a stop loss of Rs 1,174, target at Rs 1,235 and CESC with a stop loss of Rs 412, target at Rs 450.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Ashwani Gujral of ashwanigujral.com suggests buying Sun Pharma with a stop loss of Rs 388, target of Rs 404 and Cipla with a stop loss of Rs 420, target of Rs 435.

  • Sun Pharma, NCC and ACC among 10 stocks that could return 12-92% in long term

    Sun Pharma, NCC and ACC among 10 stocks that could return 12-92% in long term

    The market is likely to remain in consolidation mode in next week amid corporate earnings, Delhi assembly elections results and domestic data including IIP, CPI and WPI.

  • Nifty may underperform in 2020; ITC, SBI among 15 stocks brokerages are betting on

    Nifty may underperform in 2020; ITC, SBI among 15 stocks brokerages are betting on

    Most brokerages feel 2020 could be the year for broader markets to do well

  • Ashok Leyland and HUL among 17 quality stocks that can give 10-38% return in 2020

    Ashok Leyland and HUL among 17 quality stocks that can give 10-38% return in 2020

    Most experts see FII flows moving towards few largecaps in coming year also

  • Top buy and sell ideas by Ashwani Gujral, Mitesh Thakkar, Prakash Gaba for short term

    Top buy and sell ideas by Ashwani Gujral, Mitesh Thakkar, Prakash Gaba for short term

    Prakash Gaba of prakashgaba.com recommends buying Jubilant Foodworks with target at Rs 1620 and stop loss at Rs 1582 and SRF with target at Rs 3500 and stop loss at Rs 3380.

  • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

    Mitesh Thakkar of miteshthakkar.com recommends buying BPCL with a stop loss of Rs 533 for target of Rs 570 and NCC with a stop loss of Rs 59 for target of Rs 65.

  • Top buy and sell ideas by Ashwani Gujral, Prakash Gaba, Sudarshan Sukhani for short term

    Top buy and sell ideas by Ashwani Gujral, Prakash Gaba, Sudarshan Sukhani for short term

    Sudarshan Sukhani of s2analytics.com is of the view that one may sell Axis Bank with stop loss at Rs 735 and target of Rs 715.

  • Morgan Stanley bullish on these 2 pharma stocks which could give 32-47% return

    Morgan Stanley bullish on these 2 pharma stocks which could give 32-47% return

    Morgan Stanley also has overweight rating on Lupin with a target price at Rs 1,003, implying 47 percent potential upside from current levels as it believes the share price will rise in absolute terms over the next 30 days.

  • With 10% return likely in Nifty, CLSA likes these 10 largecaps

    With 10% return likely in Nifty, CLSA likes these 10 largecaps

    According to CLSA, GDP growth in FY20 is likely to be around 6 percent, much lower lower than the RBI's 6.9 percent projection.

  • CLSA is betting on these 8 stocks for double-digit return

    CLSA is betting on these 8 stocks for double-digit return

    Sectors with positive outlooks are real estate, small appliances and branded apparel, while outlook on autos, select staples and global commodities is more cautious.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347